Developmental delay

Delay describes a pattern, not a cause

Development varies along individual paths. A professional may use developmental delay when skills in one or more domains differ enough from applicable age-based expectations to warrant evaluation or support. The pattern may be temporary or persistent, isolated or broad; the label does not identify cause.

Developmental variation describes a different pace, sequence, or context and does not by itself meet delay criteria. A plateau is little or no observed new progress over a defined period, without loss of an established skill. Regression is loss or marked reduction of a previously acquired and reliably used skill. Check opportunity, access, health, setting, and measurement before interpreting a plateau or regression; one missed performance is neither.

Developmental difference can be respectful everyday language, though it may not carry the same clinical or program meaning. The 2025 AAP genetic-evaluation report describes global developmental delay as failure to meet expected milestones in several areas of intellectual functioning in a child younger than 5 who cannot undergo systematic intellectual assessment, with reassessment required. Other systems may use different criteria, so record age, domains, measures, threshold, and decision-maker.

A missed milestone raises a question rather than establishing delay. The CDC milestones page says its checklists do not replace standardized, validated screening. Interpret observations in light of hearing, vision, health, opportunity, language exposure, motor and communication access, culture, and setting demands.

Monitoring, screening, and evaluation have different jobs

The CDC developmental monitoring and screening page distinguishes ongoing observation from formal screening. It lists general screening at 9, 18, and 30 months and autism-specific screening at 18 and 24 months, with more screening when concerns arise. The CDC clinical screening page also separates screening from diagnosis.

The AAP report by Lipkin, Macias, the Council on Children With Disabilities, and the Section on Developmental and Behavioral Pediatrics, reaffirmed in April 2024 with reference and data updates, recommends developmental surveillance throughout childhood and further developmental or medical evaluation and referral when concerns arise. Referral to early intervention need not wait for a final diagnosis.

Developmental delay and autism can overlap

Autism and developmental delay answer different questions. An autistic child may have delays, an uneven profile, or no global delay. Language or motor delay alone does not establish autism; an autism evaluation applies its own criteria and considers developmental history, communication, behavior, health, and context.

A developmental-delay label should not absorb a loss of skill or a new pain, fatigue, sleep, motor, or communication change. When regression is reported, the 2025 AAP report notes that it may signal an acquired or neurodegenerative process and can require prompt referral to neurology or genetics. A medical clinician determines the cause and referral route; ABA observations can describe changes but do not determine medical cause.

Early-intervention eligibility uses state rules

The current U.S. Department of Education IDEA Part C page, reviewed June 12, 2026, describes the core Part C population as eligible children from birth through age 2 and their families. Eligibility may be based on delay measured with appropriate diagnostic instruments and procedures in cognitive, physical, communication, social-emotional, or adaptive development, or on a diagnosed condition with a high probability of delay. IDEA permits a state extension option for certain children who previously received Part C, so families should confirm current state age and eligibility rules.

Each state defines the extent of delay and established conditions used for eligibility, according to the department's Part C eligibility resource. Families may refer themselves directly. The state Part C lead agency or its authorized team makes the program decision under state rules. A screening result, medical diagnosis, Part C decision, school-program decision, and payer authorization are separate. Families can request the written criteria, evaluation process, service-coordination contact, procedural safeguards, and explanation of any decision.

Support should fit the child and family

A useful plan begins with strengths, priorities, accessible communication, health, and participation in real routines. Ask:

• Which skill or access barrier matters to the child and family?
• How was the concern measured, and across which languages, partners, and settings?
• Were hearing, vision, pain, sleep, motor access, and other health questions considered?
• Which supports can adults or environments provide now?
• Who is qualified to evaluate each question?
• How will assent, dissent, fatigue, benefit, and burden be monitored?

ABA may be one optional support when a qualified clinician identifies a behavior-analytic need and the family chooses it with the child's assent sought and monitored when applicable. Within scope, an ABA clinician may assess defined behavior and environmental access, but cannot diagnose developmental delay, decide Part C eligibility, rule out medical, hearing, or vision causes, or prescribe another profession's care. Keep established communication modes and AAC available. Provide accessible ways to assent, dissent, pause, and ask for help, documenting the response when safety, legal, or clinical duties limit a choice. Other professional and family supports may address other needs.

A fictional family example

Leila is a fictional 30-month-old who communicates through movement, pointing, two signs, and a few spoken words. Her family notices that unfamiliar partners often miss her messages. At a well-child visit, a validated developmental screen raises a communication concern. It supports hearing, developmental, and state Part C referrals; it does not diagnose autism or developmental delay, establish Part C eligibility, or prescribe ABA.

While evaluation proceeds, a communication board selected with Leila and her family is available alongside movement, pointing, signs, and speech. Across seven planned routines, adults provide the board in 5 of 7 routines (71%, rounded). The other two are adult access failures and are excluded from Leila's denominator. Before observation, the team defines an eligible opportunity as a natural moment to request, reject, seek help, or comment with communication access and response time. In accessible routines, Leila initiates a message in 7 of 12 eligible opportunities (58%, rounded). Partners acknowledge or respond within ten seconds to 5 of those 7 messages (71%, rounded). Access, child messages, and partner response use separate denominators.

These observations define access and partner-support questions. They do not establish cause, diagnosis, treatment effect, or long-term outcome. Qualified professionals use the fuller evaluation with family and child input, while Leila keeps communication access throughout the process.